Advertisement PBR Staff Writer, Author at Pharmaceutical Business review - Page 1605 of 4440
Pharmaceutical Business review is using cookies

ContinueLearn More
Close
 

All articles by  

Eli Lilly Releases Tasisulam Phase II Results

Eli Lilly said that the Phase II study evaluated the use of Tasisulam as a second-line treatment in patients with unresectable or metastatic melanoma. The trial’s primary objective